McDonnell, D.; Afolabi, P.R.; Niazi, U.; Wilding, S.; Griffiths, G.O.; Swann, J.R.; Byrne, C.D.; Hamady, Z.Z.
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. Cancers 2025, 17, 1150.
https://doi.org/10.3390/cancers17071150
AMA Style
McDonnell D, Afolabi PR, Niazi U, Wilding S, Griffiths GO, Swann JR, Byrne CD, Hamady ZZ.
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. Cancers. 2025; 17(7):1150.
https://doi.org/10.3390/cancers17071150
Chicago/Turabian Style
McDonnell, Declan, Paul R. Afolabi, Umar Niazi, Sam Wilding, Gareth O. Griffiths, Jonathan R. Swann, Christopher D. Byrne, and Zaed Z. Hamady.
2025. "Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma" Cancers 17, no. 7: 1150.
https://doi.org/10.3390/cancers17071150
APA Style
McDonnell, D., Afolabi, P. R., Niazi, U., Wilding, S., Griffiths, G. O., Swann, J. R., Byrne, C. D., & Hamady, Z. Z.
(2025). Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. Cancers, 17(7), 1150.
https://doi.org/10.3390/cancers17071150